Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01834755
Other study ID # 12-AOI-03
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 2013
Est. completion date June 27, 2013

Study information

Verified date November 2023
Source Centre Hospitalier Universitaire de Nice
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Highlighting the relationship between psychological and physical profiles and patient's preference to better understand the patient's treatment preference and improve the information provided.


Description:

CKD is a Public Health Problem with a prevalence of 10% in general population. For patients reaching The making decision to treat ESRD with renal replacement therapy is a complex process and needs to be shared between patients, family, physician and nephrologist. Systematic Information delivery about several treatments of ESRD is recommended for patients and his family (Hemodialysis, Peritoneal Dialysis, Kidney Transplantation and Conservative treatment). Some studies on the preference of patients for renal replacement therapy reported a choice for PD about 50% while the registers report a low diffusion of PD (around 10%). Since 2009 we propose a systematic information about the different therapeutic options for ESRD and identified some clinical characteristics associated to patient's preference. However we want to know if psychological or physical phenotype is associated to patient's preference. The objective of the study is to highlight the relationship between psychological and physical profiles and patient's preference to better understand the patient's treatment preference and improve the information provided.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date June 27, 2013
Est. primary completion date June 27, 2013
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - More than 18 years - CKD with estimated GFR below 20 ml/min/1.73m2 without dialysis treatment - Patient who accepts information delivery about treatments of ESRF - Patient who accepted and signed the informed consent - Subject beneficiary of a social security system Exclusion Criteria: - Inability to achieve psychological tests - Inability to achieve physical tests

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Evaluation of psychological phenotype


Locations

Country Name City State
France CHU de Nice - Service de Néphrologie Nice

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nice

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Comparison of different psychological and physical characteristics according to patients preference The measure is composite:
criteria evaluated for psychological phenotype are: The score of the Big Five test Scale Assess people's perception of autonomy in various life domains (EPADV-16)
The criteria evaluated for physical phenotype are:
Global physical activity assess with self-administered questionnaire of BAECKE.
Evaluation of mobility with Short Physical Performance Battery Score (SPPB)
Measure of the maximum isometric strenght of the hand with " Handgrip Strengh test"
Assessment of musculoskeletal testing of the leg with MicroFET 2 Digital Dynamometer
one day
Secondary Clinical characteristics and laboratory values Clinical characteristics (age, sex, way of life, education level, QOL, nephropathy, cardio-vascular comorbidity) and laboratory values (haemoglobin, ferritin, css, creatinine, cystatin C, phosphates, calcium, 25OHD3, PTH and CRP) associated with psychological or physical phenotypes. one day
See also
  Status Clinical Trial Phase
Completed NCT01766882 - Volume,Sodium and Blood Pressure Management in HD N/A
Completed NCT01037595 - Effect of Turmeric on Pruritus in Hemodialysis Patients Phase 0
Completed NCT02686398 - Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing Hemodialysis Phase 4
Active, not recruiting NCT04376567 - Outcomes for One-stage and Two-stage Brachial Basilic Arteriovenous Fistulas N/A
Completed NCT01990118 - Gengraf Conversion Study in Stable Renal Allograft Transplant Recipients Phase 4
Recruiting NCT01704313 - A Trial of Interrupted vs Continuous Suturing Techniques for Radiocephalic Fistulae N/A
Not yet recruiting NCT06389617 - Different Doses of Intravenous Administered Dexamethasone Effecting Brachial Plexus Supraclavicular Block N/A
Completed NCT01004627 - A Study of Routine Versus Selective Use of Ultrasound Scanning Prior to Haemodialysis Fistula Surgery N/A
Recruiting NCT02895425 - Registry for End Stage Renal Failure N/A
Not yet recruiting NCT02341547 - Effectiveness of a Biosimilar Epoetin Alfa in Stable 'End Stage Renal Failure' N/A
Completed NCT01101217 - Effect of Zinc Suplementation on Serum Hemosystein Level in Hemodialysis Patients N/A
Completed NCT01996930 - Steroid Impregnated Tape in the Treatment of Over-granulating Peritoneal Dialysis Exit Sites Phase 3
Not yet recruiting NCT01704339 - Qutenza for Critical Ischaemia in End Stage Renal Failure Phase 4
Recruiting NCT01781156 - Effect of Reducing Phosphorus Absorption on Cardiac Biomarkers in Hemodialysis Patients N/A
Completed NCT01906840 - Role of Turmeric on Oxidative Modulation in ESRD Patients Phase 1/Phase 2
Not yet recruiting NCT06378931 - Quality of Life Change in Patients Undergoing Parathyroidectomy With End-stage Renal Failure